manteia predictive medicine sa initially incorporated name geninex sa startup company created november spinoff serono swissbased biotechnology company part merckserono private aim provide preventive curative treatment guidelines common complex guidelines envisaged composed two parts company basing strategy development socalled dna colony sequencing technology commercialized illumina proprietary massive parallel technology whose development initiated late glaxowelcomes geneva biomedical research institute gbri pascal laurent farinelli work protected several patents patents publications discussed presentations international conferences end company progressing along plans towards realizing industrial instrument capable sequencing complete human genome approximately hours strategic considerations led main shareholder serono sell manteias colony dna sequencing technology uk based solexa ltd part illumina httpsenwikipediaorgwikimanteiapredictivemedicine